CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Exercise or conversion Trachtenberg Eric acquired 28,901 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 43,477 shares (option exercise)
- 4 Exercise or conversion Chief Medical Officer acquired 67,771 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 31,000 shares (option exercise)
- 4 Open-market buy Chief Operating Officer bought 10,000 shares at $5.75 ($57,500)
- 4 Open-market buy Director bought 2,534,854 shares at $7.89 ($19,999,998)
- 4 Open-market buy Director bought 6,337,135 shares at $7.89 ($49,999,995)
- 4 Open-market buy Director bought 6,337,135 shares at $7.89 ($49,999,995)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 15 · 288 filings